Medical Devices industry deals total $5.4bn globally in October 2022

Total medical devices industry deals worth $5.4bn were announced globally for October 2022, with the Thermo Fisher Scientific’s $2.6bn acquisition deal with The Binding Site Group being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked a decrease of 51.2% over the previous month of $11.07bn and a drop of 54.4% when compared with the last 12-month average of $11.85bn.

In terms of number of deals, the sector saw a drop of 31.07% with 142 deals in October 2022 when compared to the last 12-month average of 206 deals.

In value terms, Europe led the activity with deals worth $3.93bn in October 2022.

Medical Devices industry deals in October 2022: Top deals

The top five deals accounted for 81.7% of the overall value during October 2022.

The combined value of the top five deals stood at $4.41bn, against the overall value of $5.4bn recorded for the month.

The top five medical devices industry deals of October 2022 tracked by GlobalData were:

1) Thermo Fisher Scientific’s $2.6bn acquisition deal with The Binding Site Group

2) The $1.14bn acquisition of M.A. Med Alliance by Cordis

3) Nordic Capital’s $300m private equity deal for 25% stake with Equashield Medical

4) The $275m private equity of Tempus Labs by Ares Management

5) Chende Capital, SoftBank Vision Fund 2, Yiheng Capital Partners, Yuanyi Capital and Zhongwei Capital HoldingLimited’s $100m venture financing deal with Xunshi Technology